Skip to main content
OpenTrials

Clinical trial condition

Refractory Leukemia

Explore clinical trials studying Refractory Leukemia. Study availability and eligibility vary by location and protocol.

15 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Refractory Leukemia trial results

Recruiting

Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL

NCT05495035

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Qilu Hospital of Shandong University Jinan, Shandong, China
  • Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
  • Department of Hematology/Oncology, Shanghai Jiaotong University School of Medicine Affiliated Shanghai Children's Medical Center Shanghai, China
View Trial Details
Recruiting

A Study of Revumenib and Mezigdomide in People With Leukemia

NCT07356154

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +18 more
Locations
  • City of Hope Cancer Center (Data collection only) Duarte, California, United States
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
View Trial Details

Related conditions